Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6859752rdf:typepubmed:Citationlld:pubmed
pubmed-article:6859752lifeskim:mentionsumls-concept:C0035168lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0035339lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0229601lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0015137lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C2242456lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0205296lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0772162lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0729229lld:lifeskim
pubmed-article:6859752lifeskim:mentionsumls-concept:C0729231lld:lifeskim
pubmed-article:6859752pubmed:issue1lld:pubmed
pubmed-article:6859752pubmed:dateCreated1983-7-15lld:pubmed
pubmed-article:6859752pubmed:abstractText59 patients with keratinisation diseases have been received RO 10 9359. There is a clinical medicum tolerance. Biologic controls have been carried out before and after a 3 month treatment. There is a good biological tolerance for the hematopoietic, glucidic, renal and thyroid functions. Thus the hepatic tolerance is poor for the patients with a predisposition for hepatic diseases (plethorics, alcoholics).lld:pubmed
pubmed-article:6859752pubmed:languagefrelld:pubmed
pubmed-article:6859752pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6859752pubmed:citationSubsetIMlld:pubmed
pubmed-article:6859752pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6859752pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6859752pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6859752pubmed:statusMEDLINElld:pubmed
pubmed-article:6859752pubmed:issn0151-9638lld:pubmed
pubmed-article:6859752pubmed:authorpubmed-author:MoattiJ PJPlld:pubmed
pubmed-article:6859752pubmed:authorpubmed-author:BonaféJ LJLlld:pubmed
pubmed-article:6859752pubmed:authorpubmed-author:FontanBBlld:pubmed
pubmed-article:6859752pubmed:issnTypePrintlld:pubmed
pubmed-article:6859752pubmed:volume110lld:pubmed
pubmed-article:6859752pubmed:ownerNLMlld:pubmed
pubmed-article:6859752pubmed:authorsCompleteYlld:pubmed
pubmed-article:6859752pubmed:pagination23-31lld:pubmed
pubmed-article:6859752pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:meshHeadingpubmed-meshheading:6859752-...lld:pubmed
pubmed-article:6859752pubmed:year1983lld:pubmed
pubmed-article:6859752pubmed:articleTitle[Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids].lld:pubmed
pubmed-article:6859752pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6859752pubmed:publicationTypeEnglish Abstractlld:pubmed